Trials / Completed
CompletedNCT01996202
A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study assessing the safety of the combination of ipilimumab administered concurrently with radiotherapy for patients with locally advanced or unresectable melanoma and patients at high risk for recurrence after resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ipilumimab | |
| RADIATION | Radiation |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2018-09-01
- Completion
- 2018-09-01
- First posted
- 2013-11-27
- Last updated
- 2019-07-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01996202. Inclusion in this directory is not an endorsement.